BioMarin Pharmaceutical Inc.
GB ˙ LSE ˙ US09061G1013
54,65 $ ↑0,60 (1,11%)
2026-06-03
AKTIENPREIS
SecurityGB:0HNC / BioMarin Pharmaceutical Inc.
InstitutionSimplex Trading, Llc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Simplex Trading, Llc ownership in 0HNC / BioMarin Pharmaceutical Inc.

On February 11, 2026 - Simplex Trading, Llc filed a 13F-HR form disclosing ownership of 0 shares of BioMarin Pharmaceutical Inc. (GB:0HNC) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 12, 2025 disclosing 23,096 shares of BioMarin Pharmaceutical Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Simplex Trading, Llc has a history of taking positions in derivatives of the underlying security (0HNC) in the form of stock options. The firm currently holds call options representing 57,000 of underlying shares valued at $3,219,930 USD and put options representing 8,300 of underlying shares valued at $468,867 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

GB:0HNC / BioMarin Pharmaceutical Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -23,096 -100.00 0 -100.00
2025-11-12 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 23,096 23,096 1 0.0006
2025-08-05 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -4,834 -100.00 0 0.0000
2025-05-12 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 4,834 -43,409 -89.98 0 -100.00 0.0002
2025-02-11 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 48,243 48,243 3 0.0018
2024-11-08 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -8,351 -100.00 0 0.0000
2024-07-25 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 8,351 -9,287 -52.65 1 -100.00 0.0004
2024-04-25 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 17,638 -10,865 -38.12 2 -50.00 0.0009
2024-02-02 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 28,503 28,503 3 0.0018
2023-08-04 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -9,652 -100.00 0 0.0000
2023-04-27 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 9,652 9,652 1 0.0008
2023-02-02 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -8,825 -100.00 0 -100.00
2022-11-04 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 8,825 -2,397 -21.36 748 -19.48 0.0008
2022-08-03 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 11,222 280 2.56 929 10.20 0.0010
2022-05-02 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 10,942 -15,523 -58.65 843 -63.94 0.0008
2022-02-23 2021-12-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 26,465 14,151 114.92 2,338 126.33 0.0024
2022-02-04 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 12,314 0 1,033 0.0004
2021-10-28 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 12,314 -3,614 -22.69 1,033 -22.27 0.0010
2021-08-12 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15,928 -6,596 -29.28 1,329 -21.82 0.0013
2021-04-26 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 22,524 22,424 22,424.00 1,700 21,150.00 0.0031
2021-02-02 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 100 -35,899 -99.72 8 -99.71 0.0000
2020-10-14 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 35,999 10,749 42.57 2,738 -12.07 0.0037
2020-07-13 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 25,250 4,773 23.31 3,114 80.00 0.0050
2020-04-29 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 20,477 5,414 35.94 1,730 35.90 0.0031
2020-02-05 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15,063 7,688 104.24 1,273 156.14 0.0028
2019-10-15 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 7,375 7,375 497 0.0014
2019-07-26 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -5,051 -100.00 0 -100.00
2019-04-18 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,051 381 8.16 448 12.85 0.0012
2019-01-16 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 4,670 -4,553 -49.37 397 -55.59 0.0012
2018-10-23 2018-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 9,223 2,175 30.86 894 34.84 0.0029
2018-07-30 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 7,048 883 14.32 663 32.87 0.0026
2018-04-26 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 6,165 -5,317 -46.31 499 -51.22 0.0219
2018-01-10 2017-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 11,482 11,482 86.24 1,023 105.01 0.0440
2017-10-25 2017-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -2,778 -100.00 0 -100.00
2017-07-12 2017-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 2,778 -93 -3.24 252 0.00 0.0109
2017-04-21 2017-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 2,871 -12,771 -81.65 252 -80.54 0.0109
2017-01-11 2016-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15,642 -2,489 -13.73 1,295 -22.78 0.0774
2016-10-07 2016-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 18,131 1,528 9.20 1,677 29.90 0.1137
2016-07-18 2016-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 16,603 16,011 2,704.56 1,291 2,589.58 0.0863
2016-04-14 2016-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 592 592 -96.43 48 -96.28 0.0038
2016-01-20 2015-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -233 -100.00 0 -100.00
2015-10-08 2015-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 233 233 24 0.0018
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F BIOMARIN PHARMACEUTICAL CALL Call 57,000 -34.48 3,220 -37.74 n/a n/a n/a
2026-02-11 2025-12-31 13F BIOMARIN PHARMACEUTICAL CALL Call 87,000 46.71 5,170 172,233.33 n/a n/a n/a
2025-11-12 2025-09-30 13F BIOMARIN PHARMACEUTICAL CALL Call 59,300 1.72 3 0.00 n/a n/a n/a
2025-08-05 2025-06-30 13F BIOMARIN PHARMACEUTICAL CALL Call 58,300 29.84 3 0.00 n/a n/a n/a
2025-05-12 2025-03-31 13F BIOMARIN PHARMACEUTICAL CALL Call 44,900 85.54 3 200.00 n/a n/a n/a
2025-02-11 2024-12-31 13F BIOMARIN PHARMACEUTICAL CALL Call 24,200 -52.64 2 -66.67 n/a n/a n/a
2024-11-08 2024-09-30 13F BIOMARIN PHARMACEUTICAL CALL Call 51,100 -67.41 4 -75.00 n/a n/a n/a
2024-07-25 2024-06-30 13F BIOMARIN PHARMACEUTICAL CALL Call 156,800 306.22 13 300.00 n/a n/a n/a
2024-04-25 2024-03-31 13F BIOMARIN PHARMACEUTICAL CALL Call 38,600 -26.89 3 -40.00 n/a n/a n/a
2024-02-02 2023-12-31 13F BIOMARIN PHARMACEUTICAL CALL Call 52,800 -9.90 5 0.00 n/a n/a n/a
2023-11-01 2023-09-30 13F BIOMARIN PHARMACEUTICAL CALL Call 58,600 -38.25 5 -37.50 n/a n/a n/a
2023-08-04 2023-06-30 13F BIOMARIN PHARMACEUTICAL CALL Call 94,900 92.89 8 100.00 n/a n/a n/a
2023-04-27 2023-03-31 13F BIOMARIN PHARMACEUTICAL CALL Call 49,200 -35.94 5 -42.86 n/a n/a n/a
2023-02-02 2022-12-31 13F BIOMARIN PHARMACEUTICAL CALL Call 76,800 25.08 8 -99.87 n/a n/a n/a
2022-11-04 2022-09-30 13F BIOMARIN PHARMACEUTICAL CALL Call 61,400 39.86 5,204 43.08 n/a n/a n/a
2022-08-03 2022-06-30 13F BIOMARIN PHARMACEUTICAL CALL Call 43,900 39.37 3,637 49.79 n/a n/a n/a
2022-05-02 2022-03-31 13F BIOMARIN PHARMACEUTICAL CALL Call 31,500 -33.40 2,428 -41.89 n/a n/a n/a
2022-02-23 2021-12-31 13F/A BIOMARIN PHARMACEUTICAL CALL Call 47,300 35.14 4,178 42.30 n/a n/a n/a
2022-02-04 2021-12-31 13F BIOMARIN PHARMACEUTICAL CALL Call 35,000 2,936 n/a n/a n/a
2021-10-28 2021-09-30 13F BIOMARIN PHARMACEUTICAL CALL Call 35,000 0.00 2,936 0.55 n/a n/a n/a
2021-08-12 2021-06-30 13F BIOMARIN PHARMACEUTICAL CALL Call 35,000 4,554.26 2,920 -48.57 n/a n/a n/a
2021-04-26 2021-03-31 13F BIOMARIN PHARMACEUTICAL CALL Call 752 -62.90 5,678 -68.05 n/a n/a n/a
2021-02-02 2020-12-31 13F BIOMARIN PHARMACEUTICAL CALL Call 2,027 101.09 17,774 131.79 n/a n/a n/a
2020-10-14 2020-09-30 13F BIOMARIN PHARMACEUTICAL CALL Call 1,008 90.91 7,668 17.75 n/a n/a n/a
2020-07-13 2020-06-30 13F BIOMARIN PHARMACEUTICAL CALL Call 528 7.54 6,512 56.99 n/a n/a n/a
2020-04-29 2020-03-31 13F BIOMARIN PHARMACEUTICAL CALL Call 491 45.27 4,148 45.19 n/a n/a n/a
2020-02-05 2019-12-31 13F BIOMARIN PHARMACEUTICAL CALL Call 338 28.03 2,857 60.60 n/a n/a n/a
2019-10-15 2019-09-30 13F BIOMARIN PHARMACEUTICAL CALL Call 264 50.00 1,779 18.05 n/a n/a n/a
2019-07-26 2019-06-30 13F BIOMARIN PHARMACEUTICAL CALL Call 176 117.28 1,507 109.60 n/a n/a n/a
2019-04-18 2019-03-31 13F BIOMARIN PHARMACEUTICAL CALL Call 81 -47.40 719 -45.16 n/a n/a n/a
2019-01-16 2018-12-31 13F BIOMARIN PHARMACEUTICAL CALL Call 154 -13.48 1,311 -24.04 n/a n/a n/a
2018-10-23 2018-09-30 13F BIOMARIN PHARMACEUTICAL CALL Call 178 -48.10 1,726 -46.58 n/a n/a n/a
2018-07-30 2018-06-30 13F BIOMARIN PHARMACEUTICAL CALL Call 343 444.44 3,231 13,947.83 n/a n/a n/a
2018-04-26 2018-03-31 13F BIOMARIN PHARMACEUTICAL CALL Call 63 -60.13 23 -62.30 n/a n/a n/a
2018-01-10 2017-12-31 13F BIOMARIN PHARMACEUTICAL CALL Call 158 11.27 61 -33.70 n/a n/a n/a
2017-10-25 2017-09-30 13F BIOMARIN PHARMACEUTICAL CALL Call 142 79.75 92 268.00 n/a n/a n/a
2017-07-12 2017-06-30 13F BIOMARIN PHARMACEUTICAL CALL Call 79 -31.30 25 -26.47 n/a n/a n/a
2017-04-21 2017-03-31 13F BIOMARIN PHARMACEUTICAL CALL Call 115 -30.72 34 -56.41 n/a n/a n/a
2017-01-11 2016-12-31 13F BIOMARIN PHARMACEUTICAL CALL Call 166 -30.54 78 39.29 n/a n/a n/a
2016-10-07 2016-09-30 13F BIOMARIN PHARMACEUTICAL CALL Call 239 -34.70 56 143.48 n/a n/a n/a
2016-07-18 2016-06-30 13F BIOMARIN PHARMACEUTICAL CALL Call 366 -16.44 23 -83.69 n/a n/a n/a
2016-04-14 2016-03-31 13F BIOMARIN PHARMACEUTICAL CALL Call 438 89.61 141 -31.55 n/a n/a n/a
2016-01-20 2015-12-31 13F BIOMARIN PHARMACEUTICAL CALL Call 231 -56.42 206 17.71 n/a n/a n/a
2015-10-08 2015-09-30 13F BIOMARIN PHARMACEUTICAL CALL Call 530 60.61 175 -68.35 n/a n/a n/a
2015-07-08 2015-06-30 13F BIOMARIN PHARMACEUTICAL CALL Call 330 -10.08 553 -42.93 n/a n/a n/a
2015-04-21 2015-03-31 13F BIOMARIN PHARMACEUTICAL CALL Call 367 92.15 969 143.47 n/a n/a n/a
2015-03-04 2014-12-31 13F BIOMARIN PHARMACEUTICAL CALL Call 191 398 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F BIOMARIN PHARMACEUTICAL PUT Put 8,300 -80.96 469 -81.94 n/a n/a n/a
2026-02-11 2025-12-31 13F BIOMARIN PHARMACEUTICAL PUT Put 43,600 -29.90 2,591 86,266.67 n/a n/a n/a
2025-11-12 2025-09-30 13F BIOMARIN PHARMACEUTICAL PUT Put 62,200 46.01 3 50.00 n/a n/a n/a
2025-08-05 2025-06-30 13F BIOMARIN PHARMACEUTICAL PUT Put 42,600 -23.38 2 -33.33 n/a n/a n/a
2025-05-12 2025-03-31 13F BIOMARIN PHARMACEUTICAL PUT Put 55,600 -46.74 4 -50.00 n/a n/a n/a
2025-02-11 2024-12-31 13F BIOMARIN PHARMACEUTICAL PUT Put 104,400 -15.67 7 -25.00 n/a n/a n/a
2024-11-08 2024-09-30 13F BIOMARIN PHARMACEUTICAL PUT Put 123,800 30.87 9 14.29 n/a n/a n/a
2024-07-25 2024-06-30 13F BIOMARIN PHARMACEUTICAL PUT Put 94,600 33.05 8 16.67 n/a n/a n/a
2024-04-25 2024-03-31 13F BIOMARIN PHARMACEUTICAL PUT Put 71,100 -7.06 6 -14.29 n/a n/a n/a
2024-02-02 2023-12-31 13F BIOMARIN PHARMACEUTICAL PUT Put 76,500 86.13 7 133.33 n/a n/a n/a
2023-11-01 2023-09-30 13F BIOMARIN PHARMACEUTICAL PUT Put 41,100 -40.61 4 -40.00 n/a n/a n/a
2023-08-04 2023-06-30 13F BIOMARIN PHARMACEUTICAL PUT Put 69,200 40.65 6 25.00 n/a n/a n/a
2023-04-27 2023-03-31 13F BIOMARIN PHARMACEUTICAL PUT Put 49,200 -34.83 5 -42.86 n/a n/a n/a
2023-02-02 2022-12-31 13F BIOMARIN PHARMACEUTICAL PUT Put 75,500 16.15 8 -99.87 n/a n/a n/a
2022-11-04 2022-09-30 13F BIOMARIN PHARMACEUTICAL PUT Put 65,000 16.07 5,510 18.75 n/a n/a n/a
2022-08-03 2022-06-30 13F BIOMARIN PHARMACEUTICAL PUT Put 56,000 174.51 4,640 195.17 n/a n/a n/a
2022-05-02 2022-03-31 13F BIOMARIN PHARMACEUTICAL PUT Put 20,400 -62.15 1,572 -66.99 n/a n/a n/a
2022-02-23 2021-12-31 13F/A BIOMARIN PHARMACEUTICAL PUT Put 53,900 -42.96 4,762 -39.94 n/a n/a n/a
2022-02-04 2021-12-31 13F BIOMARIN PHARMACEUTICAL PUT Put 94,500 7,929 n/a n/a n/a
2021-10-28 2021-09-30 13F BIOMARIN PHARMACEUTICAL PUT Put 94,500 0.00 7,929 0.56 n/a n/a n/a
2021-08-12 2021-06-30 13F BIOMARIN PHARMACEUTICAL PUT Put 94,500 11,326.84 7,885 26.28 n/a n/a n/a
2021-04-26 2021-03-31 13F BIOMARIN PHARMACEUTICAL PUT Put 827 28.82 6,244 10.93 n/a n/a n/a
2021-02-02 2020-12-31 13F BIOMARIN PHARMACEUTICAL PUT Put 642 -20.35 5,629 -8.20 n/a n/a n/a
2020-10-14 2020-09-30 13F BIOMARIN PHARMACEUTICAL PUT Put 806 10.26 6,132 -31.99 n/a n/a n/a
2020-07-13 2020-06-30 13F BIOMARIN PHARMACEUTICAL PUT Put 731 4.88 9,016 53.10 n/a n/a n/a
2020-04-29 2020-03-31 13F BIOMARIN PHARMACEUTICAL PUT Put 697 48.61 5,889 48.52 n/a n/a n/a
2020-02-05 2019-12-31 13F BIOMARIN PHARMACEUTICAL PUT Put 469 191.30 3,965 265.44 n/a n/a n/a
2019-10-15 2019-09-30 13F BIOMARIN PHARMACEUTICAL PUT Put 161 -41.45 1,085 -53.93 n/a n/a n/a
2019-07-26 2019-06-30 13F BIOMARIN PHARMACEUTICAL PUT Put 275 -35.90 2,355 -38.19 n/a n/a n/a
2019-04-18 2019-03-31 13F BIOMARIN PHARMACEUTICAL PUT Put 429 124.61 3,810 134.32 n/a n/a n/a
2019-01-16 2018-12-31 13F BIOMARIN PHARMACEUTICAL PUT Put 191 -33.91 1,626 -41.97 n/a n/a n/a
2018-10-23 2018-09-30 13F BIOMARIN PHARMACEUTICAL PUT Put 289 0.00 2,802 2.94 n/a n/a n/a
2018-07-30 2018-06-30 13F BIOMARIN PHARMACEUTICAL PUT Put 289 191.92 2,722 5,344.00 n/a n/a n/a
2018-04-26 2018-03-31 13F BIOMARIN PHARMACEUTICAL PUT Put 99 -77.65 50 -36.71 n/a n/a n/a
2018-01-10 2017-12-31 13F BIOMARIN PHARMACEUTICAL PUT Put 443 119.31 79 146.88 n/a n/a n/a
2017-10-25 2017-09-30 13F BIOMARIN PHARMACEUTICAL PUT Put 202 -15.83 32 -65.22 n/a n/a n/a
2017-07-12 2017-06-30 13F BIOMARIN PHARMACEUTICAL PUT Put 240 43.71 92 135.90 n/a n/a n/a
2017-04-21 2017-03-31 13F BIOMARIN PHARMACEUTICAL PUT Put 167 -58.66 39 -82.67 n/a n/a n/a
2017-01-11 2016-12-31 13F BIOMARIN PHARMACEUTICAL PUT Put 404 18.82 225 112.26 n/a n/a n/a
2016-10-07 2016-09-30 13F BIOMARIN PHARMACEUTICAL PUT Put 340 30.77 106 -64.43 n/a n/a n/a
2016-07-18 2016-06-30 13F BIOMARIN PHARMACEUTICAL PUT Put 260 114.88 298 75.29 n/a n/a n/a
2016-04-14 2016-03-31 13F BIOMARIN PHARMACEUTICAL PUT Put 121 -1.63 170 246.94 n/a n/a n/a
2016-01-20 2015-12-31 13F BIOMARIN PHARMACEUTICAL PUT Put 123 -8.21 49 -84.97 n/a n/a n/a
2015-10-08 2015-09-30 13F BIOMARIN PHARMACEUTICAL PUT Put 134 0.75 326 462.07 n/a n/a n/a
2015-07-08 2015-06-30 13F BIOMARIN PHARMACEUTICAL PUT Put 133 51.14 58 114.81 n/a n/a n/a
2015-04-21 2015-03-31 13F BIOMARIN PHARMACEUTICAL PUT Put 88 83.33 27 1,250.00 n/a n/a n/a
2015-03-04 2014-12-31 13F BIOMARIN PHARMACEUTICAL PUT Put 48 2 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.